Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Lowell › NPI 1407804669
Supplier

The Lowell General Hospital

The Lowell General Hospital was paid $159.91M by Medicaid between Jan 2018 and Dec 2024, across 619 billing codes. Its largest line is 99283, emergency room visit (moderate) — 10% of everything it billed.

33Billing provider infoTHE LOWELL GENERAL HOSPITAL
LOWELL, MA 01854
33aNPI1407804669assigned 05/04/2006
33bProvider typeInstitutional Pharmacy
28Total paid$159.91M
24GClaims4,669,409
24DCodes billed619
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018815,860$27.43M
2019757,078$23.32M
2020617,566$17.34M
2021759,981$20.94M
2022738,123$22.05M
2023606,421$25.96M
2024incomplete374,380$22.87M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 10% 100,893 90,290 $16.11M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 9.3% 98,215 88,118 $14.82M
96361 Intravenous infusion, hydration; each additional hour 8.9% 41,169 35,063 $14.18M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.0% 55,764 49,654 $9.54M
59025 Fetal non-stress test 2.2% 14,419 7,403 $3.44M
G0378 Hospital observation service, per hour 1.7% 44,592 17,297 $2.78M
74177 Computed tomography, abdomen and pelvis; with contrast material 1.7% 18,528 17,567 $2.64M
70450 Computed tomography, head or brain; without contrast material 1.6% 22,190 20,400 $2.60M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.6% 3,538 3,428 $2.60M
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 1.6% 2,592 2,543 $2.57M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.5% 17,149 14,830 $2.42M
S9485 Crisis intervention mental health services, per diem 1.5% 5,923 3,228 $2.41M
607 more codes
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1.5% 17,679 $2.41M
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.3% 13,785 $2.10M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.3% 17,657 $2.05M
J9271 Injection, pembrolizumab, 1 mg 1.3% 212 $2.03M
77063 Screening digital breast tomosynthesis, bilateral 1.2% 32,540 $1.99M
76700 Ultrasound, abdominal, real time with image documentation; complete 1.2% 12,970 $1.96M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.2% 32,201 $1.93M
45380 Colonoscopy, flexible; with biopsy, single or multiple 1.2% 1,917 $1.91M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.2% 57,348 $1.84M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1.1% 24,797 $1.68M
99213 Doctor's office visit, returning patient (routine) <1% 10,850 $1.59M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 11,534 $1.52M
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 12,656 $1.47M
71046 Radiologic examination, chest; 2 views <1% 59,776 $1.34M
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 11,744 $1.30M
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 8,344 $1.22M
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 8,028 $1.20M
99214 Doctor's office visit, returning patient (more involved) <1% 7,343 $1.11M
93971 <1% 6,147 $1.06M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 43,284 $1.05M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 43,090 $1.05M
80053 Comprehensive metabolic panel <1% 209,406 $1.02M
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 5,064 $1.01M
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 225,951 $983K
76770 <1% 6,554 $968K
76830 Ultrasound, transvaginal <1% 10,913 $966K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 6,084 $955K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 37,347 $945K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 20,561 $928K
76801 <1% 8,436 $914K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 646 $893K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 9,310 $856K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 4,010 $845K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 13,971 $832K
76819 Fetal biophysical profile; without non-stress testing <1% 12,834 $820K
71275 Computed tomographic angiography, chest, with contrast material <1% 4,323 $815K
76642 <1% 8,184 $802K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 12,902 $699K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 39,532 $607K
77067 Screening mammography, bilateral, including computer-aided detection <1% 32,662 $592K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 566 $571K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 14,983 $557K
29075 <1% 2,148 $546K
93975 <1% 4,649 $544K
84443 Thyroid stimulating hormone (TSH) <1% 62,924 $534K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 13,694 $525K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 8,966 $501K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 29,061 $493K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 2,471 $468K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 17,154 $455K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 2,464 $450K
76536 <1% 3,978 $446K
94060 <1% 4,631 $444K
12001 <1% 1,899 $428K
J0875 Injection, dalbavancin, 5 mg <1% 114 $419K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 22,064 $406K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 2,881 $403K
71250 <1% 6,442 $390K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 77,019 $388K
93970 <1% 1,915 $378K
77065 Tomosynthesis, mammo <1% 6,635 $373K
A0427 Emergency ambulance ride, advanced life support <1% 12,376 $362K
80050 General health panel <1% 25,861 $354K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 54,151 $348K
87086 Culture, bacterial; quantitative colony count, urine <1% 64,917 $344K
83036 Hemoglobin; glycosylated (A1C) <1% 71,626 $328K
85027 <1% 77,958 $312K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,861 $310K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 4,122 $306K
84484 <1% 48,398 $296K
80061 Lipid panel <1% 87,704 $294K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 13,874 $290K
86481 <1% 4,994 $286K
97803 <1% 3,882 $279K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 4,791 $278K
96415 <1% 1,739 $278K
77066 Tomosynthesis, mammo <1% 4,595 $272K
12011 <1% 948 $266K
ATP14 <1% 38,036 $262K
87634 <1% 4,320 $254K
99215 Doctor's office visit, returning patient (complex) <1% 1,559 $249K
19083 <1% 185 $243K
77080 <1% 4,954 $242K
73630 <1% 9,523 $232K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 8,387 $229K
82728 <1% 28,209 $227K
73562 <1% 9,238 $226K
80048 Basic metabolic panel (calcium, ionized) <1% 65,068 $224K
72100 <1% 7,762 $219K
86803 <1% 22,803 $214K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 17,301 $211K
93017 <1% 2,207 $209K
70496 <1% 1,340 $206K
84702 <1% 17,349 $205K
47562 <1% 64 $204K
43235 <1% 238 $199K
J1756 Injection, iron sucrose, 1 mg <1% 3,260 $198K
81025 <1% 36,268 $197K
73610 <1% 8,254 $193K
83690 <1% 40,584 $182K
0002A <1% 6,139 $182K
74246 <1% 977 $174K
94727 <1% 3,827 $174K
0001A <1% 6,351 $173K
29065 <1% 622 $170K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 12,222 $165K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 34,222 $160K
81001 <1% 82,280 $159K
82607 <1% 20,471 $155K
83880 <1% 11,160 $154K
76870 <1% 1,249 $152K
87070 <1% 24,201 $151K
73030 <1% 7,058 $149K
77062 <1% 2,151 $147K
10060 <1% 765 $145K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 543 $144K
86003 <1% 2,150 $140K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 4,318 $139K
96367 <1% 3,114 $136K
87522 Neg quan hep c or qual rna <1% 4,568 $136K
83550 <1% 25,984 $133K
97602 <1% 739 $133K
94664 <1% 2,451 $132K
83735 <1% 38,624 $132K
87340 <1% 18,970 $132K
86480 <1% 3,608 $131K
70486 <1% 2,426 $130K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 1,158 $130K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 80 $129K
97162 <1% 3,329 $127K
74018 <1% 4,240 $126K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk <1% 139 $118K
87186 <1% 21,063 $117K
J0897 Injection, denosumab, 1 mg <1% 303 $116K
90715 <1% 4,598 $111K
73110 <1% 4,924 $110K
93976 <1% 919 $110K
95816 <1% 448 $108K
88307 <1% 1,283 $108K
95886 <1% 470 $107K
87653 <1% 3,611 $106K
73130 <1% 5,945 $106K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 29,589 $105K
87081 <1% 17,852 $102K
77061 <1% 1,404 $100K
85610 <1% 52,339 $96K
73502 <1% 4,711 $96K
83540 <1% 24,668 $95K
94729 <1% 3,824 $94K
71271 <1% 2,416 $91K
86850 <1% 14,255 $90K
84439 <1% 16,997 $88K
73140 <1% 3,156 $88K
82948 <1% 31,183 $86K
29125 <1% 694 $86K
36415 Collection of venous blood by venipuncture <1% 201,845 $83K
87040 <1% 11,101 $83K
12002 <1% 397 $83K
70491 <1% 453 $82K
86140 <1% 25,679 $82K
83970 <1% 6,139 $82K
97802 <1% 1,003 $81K
87902 <1% 560 $81K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 454 $81K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 646 $80K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 535 $79K
86706 <1% 11,803 $76K
88142 <1% 5,015 $74K
82105 <1% 6,261 $73K
96375 Therapeutic injection; each additional sequential IV push <1% 38,580 $71K
84703 <1% 12,708 $70K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 6,398 $69K
87147 <1% 12,558 $68K
93880 <1% 886 $67K
86762 <1% 6,005 $67K
64483 <1% 80 $65K
88342 <1% 4,888 $65K
87077 <1% 13,540 $64K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 6,835 $64K
87517 <1% 2,102 $64K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 6,243 $62K
85730 <1% 19,126 $61K
71045 Radiologic examination, chest; single view <1% 13,970 $61K
80076 <1% 24,596 $60K
72050 <1% 880 $58K
83655 <1% 5,266 $57K
82746 <1% 7,648 $57K
86618 <1% 5,318 $57K
82570 <1% 24,755 $57K
86592 <1% 18,669 $57K
74019 <1% 1,608 $56K
86038 <1% 7,394 $54K
87535 <1% 2,617 $53K
85379 <1% 7,965 $53K
72125 Computed tomography, cervical spine; without contrast material <1% 6,710 $52K
73080 <1% 2,218 $52K
84403 <1% 2,973 $52K
97161 <1% 1,147 $51K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 1,176 $51K
83021 <1% 3,408 $51K
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 690 $48K
82652 <1% 2,134 $48K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 2,850 $48K
82784 <1% 6,801 $46K
82043 <1% 20,260 $46K
0012A <1% 1,941 $46K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 593 $46K
87536 <1% 1,019 $45K
87205 <1% 15,108 $45K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 24 $44K
81003 <1% 30,658 $43K
83605 <1% 6,923 $43K
72040 <1% 1,482 $43K
86900 <1% 15,165 $43K
86360 <1% 1,965 $42K
ATP08 <1% 13,111 $42K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 10,283 $42K
0011A <1% 2,095 $41K
83001 <1% 3,167 $41K
84146 <1% 2,974 $40K
83516 <1% 4,573 $40K
77336 <1% 709 $39K
84112 <1% 560 $38K
84425 <1% 2,689 $37K
85652 <1% 24,252 $36K
84402 <1% 2,028 $35K
62323 <1% 67 $35K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 5,460 $35K
87338 <1% 3,671 $35K
86359 <1% 1,965 $34K
77386 <1% 294 $34K
84153 <1% 3,980 $33K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 611 $33K
76818 <1% 530 $33K
J1650 Injection, enoxaparin sodium, 10 mg <1% 4,242 $33K
86901 <1% 12,851 $33K
87210 <1% 8,852 $32K
76882 <1% 268 $31K
A0425 Ground mileage, per statute mile <1% 12,868 $31K
86708 <1% 4,027 $31K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,440 $30K
ATP15 <1% 6,763 $30K
87808 <1% 3,373 $30K
72072 <1% 743 $29K
J7120 Ringers lactate infusion, up to 1000 cc <1% 15,465 $29K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 39,109 $29K
J2704 Injection, propofol, 10 mg <1% 24,617 $29K
86694 <1% 2,309 $28K
88304 <1% 5,220 $28K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 2,996 $28K
80051 <1% 7,138 $27K
86704 <1% 3,560 $27K
82565 <1% 16,759 $27K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 36,338 $26K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 20,244 $26K
73590 <1% 1,289 $26K
84480 <1% 2,865 $26K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 2,884 $26K
G0105 Colorectal cancer screening; colonoscopy on individual at high risk <1% 25 $25K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 68 $25K
87088 <1% 4,948 $25K
83002 <1% 1,570 $25K
82670 <1% 1,003 $23K
81511 <1% 598 $23K
70498 <1% 1,180 $23K
86235 <1% 502 $22K
29405 <1% 85 $22K
ATP17 <1% 11,258 $21K
86376 <1% 1,799 $20K
82731 <1% 325 $20K
84270 <1% 1,136 $20K
0031A <1% 678 $20K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 16,799 $20K
82951 <1% 1,705 $20K
84156 <1% 10,178 $20K
86780 <1% 1,993 $19K
86787 <1% 2,122 $19K
83721 <1% 4,657 $19K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 13,491 $19K
80164 <1% 2,937 $18K
71101 <1% 1,240 $18K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 135 $18K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 849 $18K
86709 <1% 2,743 $18K
73564 <1% 665 $18K
J0690 Injection, cefazolin sodium, 500 mg <1% 11,445 $18K
86765 <1% 2,136 $18K
80055 <1% 763 $17K
19081 <1% 15 $17K
86431 <1% 5,061 $17K
86200 <1% 2,219 $17K
95800 <1% 76 $16K
86800 <1% 1,377 $16K
82550 <1% 10,562 $16K
80074 <1% 387 $16K
84460 <1% 9,370 $15K
87045 <1% 2,231 $15K
87899 <1% 1,689 $15K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 29 $14K
J0185 Injection, aprepitant, 1 mg <1% 56 $14K
J2270 Injection, morphine sulfate, up to 10 mg <1% 14,398 $14K
96523 <1% 486 $14K
86735 <1% 1,638 $14K
84450 <1% 7,452 $14K
96417 <1% 952 $14K
82150 <1% 3,070 $13K
82803 <1% 850 $13K
84100 <1% 13,654 $13K
ATP03 <1% 5,744 $13K
72081 <1% 121 $13K
J7050 Infusion, normal saline solution, 250 cc <1% 5,867 $13K
84520 <1% 12,965 $13K
76942 <1% 42 $12K
87046 <1% 1,793 $12K
87209 <1% 783 $12K
73090 <1% 740 $12K
84550 <1% 8,905 $11K
J1170 Injection, hydromorphone, up to 4 mg <1% 6,819 $11K
73660 <1% 258 $11K
82785 <1% 813 $11K
82465 <1% 3,930 $11K
82950 <1% 2,443 $11K
83883 <1% 1,009 $11K
J2790 Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) <1% 66 $10K
82248 <1% 7,890 $10K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 9,084 $10K
86308 <1% 2,258 $10K
93798 <1% 224 $10K
86141 <1% 1,562 $10K
85007 <1% 4,516 $10K
J7030 Infusion, normal saline solution , 1000 cc <1% 14,486 $9K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 5,486 $9K
71100 <1% 236 $9K
82627 <1% 453 $9K
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 140 $9K
J1644 Injection, heparin sodium, per 1000 units <1% 8,758 $9K
87272 <1% 1,000 $8K
85018 <1% 5,815 $8K
J3490 Unclassified drugs <1% 5,691 $8K
96376 <1% 7,910 $8K
82247 <1% 2,357 $8K
J2358 Injection, olanzapine, long-acting, 1 mg <1% 230 $8K
72110 <1% 161 $8K
84436 <1% 2,201 $7K
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 1,130 $7K
80299 <1% 1,048 $7K
88112 <1% 72 $7K
94761 <1% 5,675 $7K
A4648 Tissue marker, implantable, any type, each <1% 723 $7K
72170 <1% 953 $7K
72020 <1% 3,927 $7K
86696 <1% 390 $7K
29105 <1% 71 $7K
82985 <1% 996 $7K
74178 <1% 54 $7K
77334 <1% 51 $7K
83615 <1% 4,573 $7K
84144 <1% 361 $7K
85014 <1% 4,649 $7K
82947 <1% 4,648 $6K
97163 <1% 152 $6K
80178 <1% 1,713 $6K
J1815 Injection, insulin, per 5 units <1% 4,437 $6K
86617 <1% 505 $6K
87641 <1% 345 $6K
94618 <1% 141 $6K
82533 <1% 461 $6K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 9,787 $6K
20553 <1% 25 $6K
87177 <1% 783 $6K
88341 <1% 709 $6K
82077 <1% 1,383 $6K
84165 <1% 1,430 $6K
86160 <1% 307 $6K
83520 <1% 542 $6K
80159 <1% 652 $6K
J1453 Injection, fosaprepitant, 1 mg <1% 495 $5K
92586 <1% 16 $5K
76885 <1% 37 $5K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 2,713 $5K
84145 <1% 412 $5K
86665 <1% 200 $5K
86361 <1% 390 $5K
85045 <1% 1,692 $5K
97116 <1% 149 $5K
ATP09 <1% 2,151 $5K
29515 <1% 36 $5K
86695 <1% 387 $5K
82272 <1% 2,361 $5K
94760 <1% 5,131 $4K
87427 <1% 560 $4K
87350 <1% 475 $4K
87328 <1% 459 $4K
ATP02 <1% 1,618 $4K
87329 <1% 459 $4K
84132 <1% 1,868 $4K
90686 <1% 205 $4K
J1572 Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg <1% 16 $4K
J2060 Injection, lorazepam, 2 mg <1% 9,772 $4K
72052 <1% 59 $4K
ATP11 <1% 2,182 $4K
ATP18 <1% 2,752 $4K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 2,684 $4K
82952 <1% 1,125 $4K
ATP07 <1% 1,788 $4K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 1,640 $4K
76881 <1% 33 $4K
86334 <1% 439 $4K
76937 <1% 241 $3K
81002 <1% 1,607 $3K
83020 <1% 342 $3K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 139 $3K
93225 <1% 51 $3K
J1040 Injection, methylprednisolone acetate, 80 mg <1% 2,337 $3K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 5,235 $3K
84432 <1% 238 $3K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 3,880 $3K
29130 <1% 17 $3K
87252 <1% 116 $3K
80069 <1% 582 $3K
97166 <1% 37 $3K
ATP10 <1% 1,346 $2K
93226 <1% 51 $2K
86707 <1% 244 $2K
ATP04 <1% 928 $2K
82977 <1% 1,036 $2K
80081 <1% 38 $2K
80179 <1% 248 $2K
86147 <1% 121 $2K
80177 <1% 334 $2K
73552 <1% 71 $2K
ATP16 <1% 753 $2K
82310 <1% 1,232 $2K
87625 <1% 77 $2K
86664 <1% 155 $2K
36592 <1% 1,000 $2K
ATP13 <1% 1,017 $2K
84481 <1% 143 $2K
82140 <1% 290 $2K
86682 <1% 197 $2K
80143 <1% 341 $2K
87493 <1% 820 $2K
82040 <1% 862 $2K
90472 Immunization administration, each additional vaccine (list separately) <1% 143 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 2,084 $2K
73120 <1% 26 $2K
81050 <1% 695 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 177 $2K
87486 <1% 69 $2K
86255 <1% 194 $2K
81015 <1% 1,133 $2K
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,708 $2K
74174 <1% 13 $2K
87253 <1% 80 $2K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 57 $2K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 5,074 $2K
90688 <1% 113 $2K
82010 <1% 255 $2K
86355 <1% 63 $1K
86357 <1% 63 $1K
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 192 $1K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 11,295 $1K
90935 Hemodialysis procedure with single evaluation by a physician <1% 19 $1K
86005 <1% 200 $1K
J1790 Injection, droperidol, up to 5 mg <1% 680 $1K
86225 <1% 126 $1K
86364 <1% 185 $1K
J1630 Injection, haloperidol, up to 5 mg <1% 2,799 $1K
76820 <1% 38 $1K
86039 <1% 147 $1K
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) <1% 23 $1K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 10,702 $1K
84075 <1% 464 $1K
J2469 Injection, palonosetron hcl, 25 mcg <1% 679 $1K
87255 <1% 43 $1K
88313 <1% 977 $1K
C9290 Injection, bupivacaine liposome, 1 mg <1% 84 $1K
86701 <1% 159 $1K
C9113 Injection, pantoprazole sodium, per vial <1% 3,944 $996.36
84154 <1% 154 $940.07
J1010 Injection, methylprednisolone acetate, 1 mg <1% 388 $901.30
77072 <1% 14 $873.73
C1781 Mesh (implantable) <1% 14 $873.47
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 394 $848.50
94690 <1% 408 $827.88
73060 <1% 26 $814.27
82378 <1% 104 $796.25
72070 <1% 13 $772.03
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 12 $743.04
97597 <1% 63 $742.41
83498 <1% 31 $718.62
J1030 Injection, methylprednisolone acetate, 40 mg <1% 44 $687.08
86663 <1% 56 $684.26
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 18 $674.97
96368 <1% 146 $667.96
87075 <1% 95 $660.97
87184 <1% 115 $656.58
J8540 Dexamethasone, oral, 0.25 mg <1% 3,844 $655.07
83519 <1% 50 $621.82
71111 <1% 26 $567.83
J3370 Injection, vancomycin hcl, 500 mg <1% 1,202 $511.77
88173 <1% 29 $484.50
99218 <1% 26 $458.50
83993 <1% 40 $431.00
73000 <1% 13 $427.97
J3480 Injection, potassium chloride, per 2 meq <1% 806 $427.49
87106 <1% 44 $370.22
86335 <1% 28 $364.18
82103 <1% 33 $363.55
81599 <1% 162 $358.40
84207 <1% 13 $342.01
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg <1% 122 $330.28
93923 <1% 13 $329.10
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 2,319 $328.18
J2470 Injection, pantoprazole sodium, 40 mg <1% 249 $325.61
83718 <1% 51 $321.37
ATP06 <1% 147 $307.04
C1769 Guide wire <1% 1,113 $295.50
G0008 Administration of influenza virus vaccine <1% 307 $282.83
95806 <1% 13 $275.40
82164 <1% 26 $271.58
82390 <1% 30 $261.17
85004 <1% 99 $248.20
85613 <1% 31 $246.64
86705 <1% 39 $245.41
81596 <1% 83 $244.48
86256 <1% 16 $222.18
94762 <1% 86 $218.71
87660 <1% 12 $194.48
87510 <1% 12 $194.48
87480 <1% 12 $194.48
85049 <1% 42 $185.08
86060 <1% 27 $176.74
J1596 Injection, glycopyrrolate, 0.1 mg <1% 281 $176.49
86692 <1% 13 $174.30
J0571 Buprenorphine, oral, 1 mg <1% 440 $155.81
84155 <1% 187 $152.52
82365 <1% 13 $147.94
ATP12 <1% 93 $139.50
80197 <1% 74 $133.21
87270 <1% 12 $131.28
80175 <1% 59 $128.00
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 74 $126.67
84478 <1% 45 $119.33
88172 <1% 17 $118.77
P9016 Red blood cells, leukocytes reduced, each unit <1% 13 $113.10
80185 <1% 29 $109.36
85048 <1% 102 $102.20
J1171 Injection, hydromorphone, 0.1 mg <1% 98 $97.15
90716 <1% 12 $95.19
ATP05 <1% 44 $90.89
90734 <1% 24 $89.90
J0640 Injection, leucovorin calcium, per 50 mg <1% 23 $89.56
J3411 Injection, thiamine hcl, 100 mg <1% 14 $86.91
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 23 $82.39
86015 <1% 13 $77.97
87341 <1% 12 $77.02
70360 <1% 14 $74.43
89051 <1% 24 $74.26
80503 <1% 21 $71.29
84479 <1% 52 $68.85
86593 <1% 14 $56.28
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg <1% 15 $49.67
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 1,315 $47.50
ATP19 <1% 12 $34.23
82270 <1% 13 $30.88
80156 <1% 43 $28.31
84300 <1% 14 $25.15
J1920 Injection, labetalol hydrochloride, 5 mg <1% 12 $20.66
J9190 Injection, fluorouracil, 500 mg <1% 23 $19.78
96411 <1% 74 $15.90
87269 <1% 14 $10.94
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 109 $10.22
J3470 Injection, hyaluronidase, up to 150 units <1% 29 $9.33
J7605 Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms <1% 43 $8.52
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 27 $7.23
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 34 $5.00
J1940 Injection, furosemide, up to 20 mg <1% 134 $3.16
J1836 Injection, metronidazole, 10 mg <1% 19 $1.88
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 18 $1.36
91300 <1% 3,726 $0.23
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography 0% 14 $0.00
J1956 Injection, levofloxacin, 250 mg 0% 125 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 0% 282 $0.00
C1780 Lens, intraocular (new technology) 0% 206 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 301 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 317 $0.00
A9575 Injection, gadoterate meglumine, 0.1 ml 0% 168 $0.00
76376 0% 120 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 13 $0.00
J7510 Prednisolone oral, per 5 mg 0% 27 $0.00
J8499 Prescription drug, oral, non chemotherapeutic, nos 0% 119 $0.00
84080 0% 12 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 109 $0.00
80320 0% 25 $0.00
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 0% 367 $0.00
91301 0% 816 $0.00
77001 0% 15 $0.00
C1892 Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away 0% 79 $0.00
V2632 Posterior chamber intraocular lens 0% 191 $0.00
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 0% 57 $0.00
87640 0% 99 $0.00
99156 0% 13 $0.00
91303 0% 187 $0.00
36591 0% 32 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 16 $0.00
J3360 Injection, diazepam, up to 5 mg 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGREEN, SUSAN (EVP CHIEF FINANCIAL OFFICER)
Parent organizationCIRCLE HEALTH, INC.
Same official

Other billing entities under GREEN, SUSAN

Full network →
ProviderLocationPaid
Melrosewakefield Healthcare, INC.Medford, MA$37.82M
LGH Merrimack Valley Cardiology Associates, LLCNorth Chelmsford, MA$1.48M
DO Not Use - the Lowell General HospitalLowell, MA$26K
Melrosewakefield Healthcare, INC.Medford, MA$4K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.